适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •1. People with Severe Malaria or signs of severe malaria (e.g. loss of consciousness, convulsions, etc.)
- •2. Those residing within the community unit.
- •3. Those who consent to participate will be diagnosed.
排除标准
- •Those unwilling to give consent will be excluded from this study.
研究者
相似试验
尚未招募
不适用
Oral Cancer Detection (OC-DETECT)CTRI/2021/07/035199ational Cancer Institute
进行中（未招募）
不适用
未命名试验-MedDRA version: 16.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-004463-41-PTMedica Scientia Innovation Research (MedSIR ARO)60
进行中（未招募）
不适用
未命名试验-MedDRA version: 15.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-004463-41-ESMedica Scientia Innovation Research (MedSIR ARO)60
进行中（未招募）
1 期
/AMedDRA version: 18.0 Level: PT Classification code 10007515 Term: Cardiac arrest System Organ Class: 10007541 - Cardiac disordersEUCTR2014-002010-24-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)462
尚未招募
1 期
Clinical observation of modified Buzhong Yiqi decoction combined with PKEP in the treatment of BPH with DBenign Prostatic HyperplasiaITMCTR2200006857Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine